We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Osteopore Limited is a medical instruments & supplies business based in Australia. Osteopore shares (OSX) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Osteopore has a trailing 12-month revenue of around $1.5 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | $0.26 - $0.645 |
|---|---|
| 50-day moving average | $0.3011 |
| 200-day moving average | $0.4069 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.023 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.275
| 1 week (2021-10-19) | 1.85% |
|---|---|
| 1 month (2021-09-24) | -8.33% |
| 3 months (2021-07-26) | -27.63% |
| 6 months (2021-04-26) | -43.88% |
| 1 year (2020-10-26) | -46.08% |
|---|---|
| 2 years (2019-10-25) | -68.75% |
| Revenue TTM | $1.5 million |
|---|---|
| Gross profit TTM | $955,326 |
| Return on assets TTM | -21.53% |
| Return on equity TTM | -53.25% |
| Profit margin | -181.43% |
| Book value | 0.065 |
| Market capitalisation | $31.7 million |
TTM: trailing 12 months
We're not expecting Osteopore to pay a dividend over the next 12 months.
Over the last 12 months, Osteopore 's shares have ranged in value from as little as $0.26 up to $0.645. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Osteopore 's is 1.4679. This would suggest that Osteopore 's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Osteopore Limited designs, develops, and markets bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications. It specializes in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing. The company offers Osteoplug, a bioresorbable implant, which is used for covering trephination burr holes in neurosurgery; Osteomesh, a bioresorbable implant that is used in craniofacial surgery to repair various types of fractures, such as orbital floor fracture, as well as to fill surgical defects; and Osteostrip. It operates in Singapore, Korea, Vietnam, and internationally. The company was founded in 2003 and is headquartered in Singapore.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Shares in the wealth management giant have been largely stable in the last 6 months.
Everything we know about the Judo Capital Holdings IPO, plus information on how to buy in.
Everything we know about the Alloggio Group IPO, plus information on how to buy in.
Everything we know about the Larvotto Resources IPO, plus information on how to buy in.
Everything we know about the Vulcan Steel IPO, plus information on how to buy in.
Everything we know about the Artrya IPO, plus information on how to buy in.
Everything we know about the 8 Au IPO, plus information on how to buy in.
Everything we know about the Radiopharm Theranostics IPO, plus information on how to buy in.
The online retailer’s shares have lost more than half their value in the last 12 months.
